Inmed Pharmaceuticals Inc (INM)

Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	24.17%2.84	2.29	2.22	2.40	2.31
Research and Development	62.16%1.02	0.63	0.58	0.11	0.91
Depreciation and Amortization	2.81%0.05	0.05	0.05	0.05	0.05
Income/Loss From Continuing Operations Before Tax	37.65%-2.79	-2.03	-1.73	-1.79	-2.12
Income/Loss From Continuing Operations After Tax	37.65%-2.79	-2.03	-1.73	-1.79	-2.12
Income/Loss From Discontinued Operations, Net Of Tax	-0.17	-	-	-	-
	46.25%-2.97	-2.03	-1.73	-1.79	-2.12
Attributable To Parent	46.25%-2.97	-2.03	-1.73	-1.79	-2.12
Basic Average Shares	2.37%4.05	3.95	3.95	0.17	1.10
Diluted Average Shares	2.37%4.05	3.95	3.95	0.17	1.10
Basic Earnings Per Share	43.14%-0.73	-0.51	-0.44	-0.43	-1.94
Diluted Earnings Per Share	43.14%-0.73	-0.51	-0.44	-0.43	-1.94